The chromatin remodeler SMARCD3 regulates cell cycle progression and its expression predicts survival outcome in ER+ breast cancer
R. Tropee, B. L. de la Pena Avalos, M. Gough, C. Snell, P. H. G. Duijf, E. Dray
This paper shows SMARCD3 expression correlates with survival in ER+ breast cancer and regulates cell cycle progression, suggesting it as a prognostic biomarker and tumor suppressor.
bioRxiv · Jul 2, 2019 · PreprintCancer Biology